Cargando…

Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs

OBJECTIVE: To investigate whether calprotectin (S100A8/A9 or MRP8/14), an inflammatory complex released by monocytes, could indicate residual subclinical inflammation in rheumatoid arthritis (RA) patients who are in stable remission on disease-modifying anti-rheumatic drugs (DMARDs) and serve as a m...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Moel, Emma C., Rech, Jürgen, Mahler, Michael, Roth, Johannes, Vogl, Thomas, Schouffoer, Anne, Goekoop, Robbert J., Huizinga, Tom W. J., Allaart, Cornelia F., Toes, René E. M., Schett, Georg, van der Woude, Diane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894482/ https://www.ncbi.nlm.nih.gov/pubmed/31805992 http://dx.doi.org/10.1186/s13075-019-2064-y

Ejemplares similares

Baseline autoantibody profile in rheumatoid arthritis is associated with early treatment response but not long-term outcomes
por: de Moel, Emma C., et al.
Publicado: (2018)

In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response
por: de Moel, Emma C., et al.
Publicado: (2019)

Predictive value of serum calprotectin (S100A8/A9) for clinical response after starting or tapering anti-TNF treatment in patients with rheumatoid arthritis
por: Tweehuysen, Lieke, et al.
Publicado: (2018)

Calprotectin in rheumatic diseases: a review
por: Kopeć-Mędrek, Magdalena, et al.
Publicado: (2016)

Glycobiology of rheumatic diseases
por: Kissel, Theresa, et al.
Publicado: (2022)

In rheumatoid arthritis patients, total IgA1 and IgA2 levels are elevated: implications for the mucosal origin hypothesis
por: Derksen, Veerle F A M, et al.
Publicado: (2022)

Relapse of SARS upon tapering corticosteroid
por: Chien, Jung-Yien, et al.
Publicado: (2004)

Calprotectin in Patients with Rheumatic Immunomediated Adverse Effects Induced by Checkpoints Inhibitors
por: Frade-Sosa, Beatriz, et al.
Publicado: (2023)

Expression and Function of S100A8/A9 (Calprotectin) in Human Typhoid Fever and the Murine Salmonella Model
por: De Jong, Hanna K., et al.
Publicado: (2015)

Geo-epidemiology of autoantibodies in rheumatoid arthritis: comparison between four ethnically diverse populations
por: de Moel, Emma C., et al.
Publicado: (2023)

Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment
por: Rech, Juergen, et al.
Publicado: (2016)

New risk model is able to identify patients with a low risk of progression in systemic sclerosis
por: van Leeuwen, Nina Marijn, et al.
Publicado: (2021)

Association Between Bone Mineral Density and Autoantibodies in Patients With Rheumatoid Arthritis
por: Amkreutz, Josephine A. M. P., et al.
Publicado: (2021)

Comparison between low disease activity or DAS remission as treatment target in patients with early active rheumatoid arthritis
por: Akdemir, Gülşah, et al.
Publicado: (2018)

Calprotectin (S100A8/A9) in Familial Mediterranean Fever
por: Pepper, R, et al.
Publicado: (2015)

Osteoimmunology in rheumatic diseases
por: Schett, Georg
Publicado: (2009)

Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis
por: Cypers, H, et al.
Publicado: (2016)

Extraction, isolation, and concentration of calprotectin antigen (S100A8/S100A9) from granulocytes
por: Nilsen, Tom, et al.
Publicado: (2018)

Impact of Exercise Intensity on Calprotectin Levels in Healthy Volunteers and Patients with Inflammatory Rheumatic Diseases
por: Xavier, Andy, et al.
Publicado: (2021)

An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting
por: van Heemst, Jurgen, et al.
Publicado: (2015)

An Inflammation Loop Orchestrated by S100A9 and Calprotectin Is Critical for Development of Arthritis
por: Cesaro, Annabelle, et al.
Publicado: (2012)

Calprotectin (S100A8/S100A9) and Myeloperoxidase: Co-Regulators of Formation of Reactive Oxygen Species
por: Bøyum, Arne, et al.
Publicado: (2010)

S-Calprotectin (S100A8/S100A9): A Potential Marker of Inflammation in Patients with Psoriatic Arthritis
por: Hansson, Claes, et al.
Publicado: (2014)

From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis
por: Inciarte-Mundo, José, et al.
Publicado: (2022)

Crosslinking of microtubules and actin filaments by S100A8/S100A9
por: Wolf, M, et al.
Publicado: (2009)

Consecutive fecal calprotectin measurements for predicting relapse in pediatric Crohn’s disease patients
por: Foster, Alice Jane, et al.
Publicado: (2019)

Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease
por: Kittanakom, Saranya, et al.
Publicado: (2017)

The effect of silver fibre gloves on Raynaud’s phenomenon in patients with systemic sclerosis: a double-blind randomized crossover trial
por: Liem, Sophie I E, et al.
Publicado: (2022)

Involvement of calprotectin (S100A8/A9) in molecular pathways associated with HNSCC
por: Khammanivong, Ali, et al.
Publicado: (2016)

Earlier is better when treating rheumatoid arthritis: but can we detect a window of opportunity?
por: Bergstra, Sytske Anne, et al.
Publicado: (2020)

A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse
por: Horowitz, Mark Abie, et al.
Publicado: (2021)

Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis
por: Markusse, Iris M, et al.
Publicado: (2014)

Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapy
por: Gernert, Michael, et al.
Publicado: (2022)

Fecal Calprotectin for predicting Relapse and Activity in Patients with Crohn’s Disease: A Meta-analysis
por: Zhuge, Ying, et al.
Publicado: (2016)

LIAISON(®) Calprotectin for the prediction of relapse in quiescent ulcerative colitis: The EuReCa study
por: Fiorino, Gionata, et al.
Publicado: (2022)

Circulating Calprotectin as a Predictive and Severity Biomarker in Patients with COVID-19
por: Norman, Gary L., et al.
Publicado: (2022)

Correction to: A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse
Publicado: (2022)

Frequency of joint inflammation is associated with local joint damage progression in rheumatoid arthritis despite long-term targeted treatment
por: Heckert, Sascha L, et al.
Publicado: (2023)

Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis
por: Jarlborg, Matthias, et al.
Publicado: (2020)

Diagnostic Accuracy of Fecal Calprotectin for Predicting Relapse in Inflammatory Bowel Disease: A Meta-Analysis
por: Shi, Jin-Tong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ep5vlfuh8bqbof3f0qsalllq25